Jab hope to treat blocked arteries

Hydrogen sulphide could be used to treat heart failure, US researchers have claimed.

The researchers, led by Professor David Lefer from Emory University School of Medicine in Atlanta, developed a model for inducing heart failure in mice by blocking their left coronary arteries.

They then administered hydrogen sulphide intravenously once a day over the course of a week.

Four weeks after artery blockage, they found that mice which had been treated with hydrogen sulphide had an ejection fraction, a measure of heart function, about a third larger than the control mice.

The research team concluded that the study demonstrated that hydrogen sulphide could be used to blunt the impact of heart failure on heart function and mortality.

The findings were presented at the annual American Heart Association scientific sessions in New Orleans last week.


Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

Female GP on a phone call wearing a headset

Seeing patients in person after multiple remote consultations

Dr Ellie Mein, medico-legal adviser at the Medical Defence Union (MDU), suggests...


Golden hello scheme brings in almost 3,000 new GP partners

Almost 3,000 GPs have become partners for the first time under a scheme offering...


Government confirms £2.45 core pay uplift to support 6% practice pay rise

Global sum payments per weighted patient will rise from £102.28 to £104.73 for 2023/24...

Nurse giving elderly man the flu vaccination

Flu vaccination prevented 25,000 hospitalisations last year

Health officials are urging vulnerable people to come forward for their flu jab after...

BMA strikes

Public blame government for long NHS waits as three-day strike begins

Three times as many people blame the government for the record 7.7m NHS waiting list...

GP typing at computer

GP practices asked to switch on data sharing with UK Biobank

GP practices have been asked to share patient data with the biomedical database UK...